AP-22408 is a Src tyrosine kinase inhibitor. References: Rucci N, Susa M, Teti A. Inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases. Anticancer Agents Med Chem. 2008 Apr;8(3):342-9. Review. PubMed PMID: 18393792.

纯度：≥98%

CAS：268741-43-1